Assessing predictors of outcomes in STEMI patients undergoing PCI
Assessment of Culprit-SYNTAX Score and No-reflow PIANO Score as Predictors of In-hospital and Short-term Clinical Outcomes in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
This study is trying to see if certain scoring systems can help doctors predict complications in patients with severe heart attacks who are getting a specific heart procedure.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Sex | All |
| Sponsor | Assiut University Academic / other |
| Locations | 1 site (Assiut) |
| Trial ID | NCT06123793 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the culprit-SYNTAX score and no-reflow PIANO scores as potential predictors of in-hospital and short-term clinical outcomes in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Given the high risk of adverse events associated with STEMI, the study seeks to identify which patients are at greater risk of complications such as death and reinfarction. By analyzing these scoring systems, the research hopes to improve risk stratification and management of STEMI patients in clinical practice.
Who should consider this trial
Good fit: Ideal candidates for this study are patients experiencing their first episode of STEMI who are undergoing primary PCI.
Not a fit: Patients who have received thrombolytic therapy, have a history of previous CABG or PCI, or have other specific cardiac conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the ability to predict adverse outcomes in STEMI patients, leading to better-targeted interventions and improved patient care.
How similar studies have performed: Other studies have shown success in using scoring systems to predict outcomes in STEMI patients, indicating that this approach is supported by existing research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients presented with 1st episode of STEMI and undergoing primary PCI. For 1 year duration. - Exclusion Criteria: 1. Patient with STEMI in which thrombolytic therapy was used. 2. Patient with a history of previous CABG surgery. 3. Patient with a history of previous PCI. 4. Patient with a history of previous STEMI. 5. Patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) 6. Patient with spontaneous coronary artery dissection (SCAD).
Where this trial is running
Assiut
- Abdelrahman Ragab — Assiut, Egypt (Recruiting)
Study contacts
- Study coordinator: Abdelrahman R. Kamel, MBBS
- Email: Ab.ragabk@gmail.com
- Phone: +20 01002251849
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.